Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses

NCT02538211 is registered in ClinicalTrials.gov with Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) as lead sponsor.

NCT NCT02538211
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02538211 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses
Lead sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2015
Completion date
February 28, 2017
Enrollment
63 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intestinal bacteria flora disturbance, reaction - vaccine nos, rotavirus infections, streptococcal pneumonia, tetanus